pomalidomide - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
POMALIDOMIDE SANDOZ pomalidomide 2 mg capsule blister pack AUST R: 352570Active ingredients:
pomalidomide
Dosage form:
Capsule, hard
Sponsor:
Sandoz Pty Ltd
Phone:
1800726369
|
From
31 Aug 2026
to
06 Nov 2026
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
Alternative brands are available.
|
POMALYST pomalidomide 1 mg capsule blister pack AUST R: 212657Active ingredients:
pomalidomide
Dosage form:
Capsule
Sponsor:
Bristol-Myers Squibb Australia Pty Ltd
Phone:
1800067567
|
Deletion from market:
31 Mar 2027
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available.
|
POMALYST pomalidomide 2 mg capsule blister pack AUST R: 212654Active ingredients:
pomalidomide
Dosage form:
Capsule
Sponsor:
Bristol-Myers Squibb Australia Pty Ltd
Phone:
1800067567
|
Deletion from market:
31 Mar 2027
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available.
|
POMALYST pomalidomide 3 mg capsule blister pack AUST R: 212656Active ingredients:
pomalidomide
Dosage form:
Capsule
Sponsor:
Bristol-Myers Squibb Australia Pty Ltd
Phone:
1800067567
|
Deletion from market:
31 Mar 2027
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available.
|
POMALYST pomalidomide 4 mg capsule blister pack AUST R: 212655Active ingredients:
pomalidomide
Dosage form:
Capsule
Sponsor:
Bristol-Myers Squibb Australia Pty Ltd
Phone:
1800067567
|
Deletion from market:
31 Mar 2027
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available.
|